The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Kadmon Oceania Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
2 result(s) found, displaying 1 to 2
-
Prescription medicine decision summaryTGA decision: Rholistiq (belumosudil mesilate) is approved to treat chronic graft-versus-host disease (GVHD)
-
Prescription medicine registrationActive ingredients: belumosudil mesilate.